标题
Newer antibacterial drugs for a new century
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 19, Issue 2, Pages 215-234
出版商
Informa Healthcare
发表日期
2010-01-07
DOI
10.1517/13543780903505092
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent
- (2009) R. Schaadt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- P1A Recombinant -Lactamase Prevents Emergence of Antimicrobial Resistance in Gut Microflora of Healthy Subjects during Intravenous Administration of Ampicillin
- (2009) A.-M. Tarkkanen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including -Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
- (2009) C. Vidaillac et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa
- (2009) M. Sabet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II
- (2009) C. S. Lunde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of NXL104 in Combination with -Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
- (2009) Ronald Gounden et al. BMC INFECTIOUS DISEASES
- Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*
- (2009) Jean Chastre et al. CRITICAL CARE MEDICINE
- Helicobacter Pylori associated global gastric cancer burden
- (2009) Sam et al. Frontiers in Bioscience-Landmark
- Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance
- (2009) J. Feng et al. GENOME RESEARCH
- Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections
- (2009) M. Montero et al. INFECTION
- Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms
- (2009) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
- (2009) N. Aoki et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
- (2009) G. A. McKay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin
- (2009) F. F. Arhin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity
- (2009) C. Oefner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selection for High-Level Telithromycin Resistance in Staphylococcus aureus Yields Mutants Resulting from an rplB-to-rplV Gene Conversion-Like Event
- (2008) D. R. Gentry et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections
- (2008) K. M. Amsler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci
- (2008) G. T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus
- (2008) G. T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria
- (2008) K. M. Krause et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and Pseudomonas aeruginosa
- (2008) T. A. Davies et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection
- (2008) T. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
- (2008) G. J. Noel et al. CLINICAL INFECTIOUS DISEASES
- Effect of Clarithromycin in Patients with Sepsis and Ventilator‐Associated Pneumonia
- (2008) Evangelos J. Giamarellos‐Bourboulis et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study
- (2008) Álvaro Réa-Neto et al. CURRENT MEDICAL RESEARCH AND OPINION
- Antivirulence as a new antibacterial approach for chemotherapy
- (2008) Sonia Escaich CURRENT OPINION IN CHEMICAL BIOLOGY
- Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin
- (2008) Carlos Bergallo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Novel β-lactam antibiotics and inhibitor combinations
- (2008) Matteo Bassetti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin
- (2008) Jean–François Rossignol et al. GASTROENTEROLOGY
- Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study
- (2008) I. Florescu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
- (2008) K. Vasilev et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
- (2008) P. Meers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
- (2008) Rosemarie O’Shea et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
- (2008) Sung Joon Kim et al. JOURNAL OF MOLECULAR BIOLOGY
- Co-opting the Cell Wall in Fighting Methicillin-ResistantStaphylococcus aureus: Potent Inhibition of PBP 2a by Two Anti-MRSA β-Lactam Antibiotics
- (2008) Adriel Villegas-Estrada et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Telithromycin and the FDA: implications for the future
- (2008) David M Shlaes et al. LANCET INFECTIOUS DISEASES
- A nuclear receptor-like pathway regulating multidrug resistance in fungi
- (2008) Jitendra K. Thakur et al. NATURE
- Cell-division inhibitors: new insights for future antibiotics
- (2008) Rowena L. Lock et al. NATURE REVIEWS DRUG DISCOVERY
- The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
- (2008) S. P. S. Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MICROBIOLOGY: Desperately Seeking New Antibiotics
- (2008) D. J. Payne SCIENCE
- A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
- (2008) C.-I Liu et al. SCIENCE
- Targeting QseC Signaling and Virulence for Antibiotic Development
- (2008) D. A. Rasko et al. SCIENCE
- An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
- (2008) D. J. Haydon et al. SCIENCE
- Neospora caninum: Functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides
- (2007) Joachim Müller et al. EXPERIMENTAL PARASITOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started